Introduction
Epilepsy is the most frequently occurring chronic neurological disorders, characterized by seizures, affecting up to 50 million people worldwide. Many patients with epilepsy do not respond well to the currently available antiepileptic drugs, thus identifying new, active, compounds remains an important challenge. Because epilepsy has a long history as a relatively common neurological disorder, it is reasonable to anticipate plant-based treatments being used over the long term [1, 2] . Representatives of the Apiaceae family have been a popular epilepsy treatment for a long time [1] , with the particular biologically active mechanism possibly associated with a high content of furanocoumarins in these plants.
Pastinaca sativa L. (Apiaceae) is a plant used in European traditional medicine, including Poland [3] .
The use of wild parsnip for treatment of epilepsy can be found in herbal remedies of the 16 th and 17 th centuries, including those of Mattioli and Tabernaemontanus [2] . These data emerged from a study performed by Adams et al. [1] , who described more than 160 plant species used to treat epilepsy, which were included in nine of the most important European herbal remedies of this period. It was concluded that a majority of these plants had not been investigated pharmacologically with respect to their potential antiepileptic activity according to contemporary standards. Pharmacological evidence was only available for a few of the described plants [2] . There is, however, insufficient evidence to indicate the phytochemical constituents responsible for this activity. Previous experiments in this laboratory demonstrated the potent activity of furanocoumarins isolated from Angelica archangelica L. (Apiaceae) as antiepileptic agents. One of the active compounds was the furanocoumarin imperatorin, which significantly raised the threshold for electroconvulsions in mice, and potentiated the anticonvulsant activity of selected current antiepileptic drugs [4] .
In previous studies, xanthotoxin, a structural analogue of psoralen, and one of the main constituents of roots of Pastinaca sativa, was also evaluated. At a dose 300 mg kg -1 , i.p., xanthotoxin, like imperatorin, produced demonstrable anticonvulsant activity in mice at four pre-treatment times [5] . Xanthotoxin is also known for its central nervous system activity, e.g. as an inhibitor of monoamine oxidase, acetylcholinesterase, and butyrylcholinesterase [6, 7] . Thus, the aim of this study was to continue examining the antiepileptic activity of xanthotoxin, and to determine the ED 50 value. In order to provide for the efficient isolation of xanthotoxin from the plant, high-performance counter-current chromatography (HPCCC) was used. HPCCC does not require a solid stationary phase since it relies solely on the partitioning of a sample between the two phases of an immiscible solvent system. When compared with traditional methods of separation, counter-current chromatography demonstrates a number of advantages, including no irreversible adsorption, less expensive solvents, total recovery of the injected sample, a low risk for sample denaturation, and low solvent consumption [8] .
Experimental Procedures

General experimental procedures
The hydrodynamic HPCCC instrument used in the present study was a Spectrum model (Dynamic Extractions, Slough, UK) multilayer coil-planet J-type centrifuge, equipped with either two analytical coils connected in series (wrapped with polytetrafluoroethylene PTFE tubing, 0.8 mm i.d., 22 ml total volume) or two preparative coils (1.6 mm i.d., 137 ml total volume). A model Alpha 10 pump was used to pump solvent, and monitoring of the effluent was achieved by UV with a model Saphire (ECOM, Prague, Czech Republic) at 254 nm. Fractions were collected manually at one-minute intervals.
The HPLC system (Shimadzu, Japan) consisted of a quaternary pump (LC-20AD), an autosampler (SIL-20A HT), and a photodiode array detector (SPD-M20A), controlled by a computer running LabSolutions LC/GC software (Shimadzu, Japan).
Separations were achieved with a reversed-phase column (Phenomenex C 18 , 4.6 × 250 mm, 4 μm particle size) and a gradient MeOH (A)-water (B) mixture was employed as the mobile system as follows: 0 min, 50% A in B; 5 min, 60% A in B; 25 min, 80% A in B; 30-40 min, 100% A. The flow rate was kept constant at 1.0 mL min -1 , and the peaks were monitored at 254 nm.
All of the organic solvents used for extraction and isolation were obtained from the Polish Chemical Reagent (Gliwice, Poland) and were analytical reagent grade. Methanol for HPLC was of chromatographic grade (J.T. Baker Inc., Netherlands), and water used was purified using a Millipore laboratory ultra pure water system (Simplicity TM system, Millipore, Molsheim, France). The standard of xanthotoxin was obtained from Sigma Aldrich (St. Louis, MO, USA).
Plant material
Fruits of cultivated Pastinaca sativa L. were obtained from the Medicinal Plant Garden, Department of Pharmacognosy, Medical University in Lublin, Poland, in the summer of 2010. The species was identified by specialists in botany, and a voucher specimen (17/20) is kept in the Department of Pharmacognosy with the Medicinal Plant Unit. Extractions were derived from ground, air-dried fruits (50 g) and dichloromethane under reflux three times (100 mL of solvent each time, 30 min). The obtained extracts were combined and evaporated to yield the crude extract (7.03 g).
High-performance counter-current chromatographic (HPCCC) separation
High-performance counter-current chromatography was used to separate xanthotoxin from the crude extracts. The 1:1:1:1 n-heptane-ethyl acetate-methanol-water system was used. The coils, without rotation, were first filled with the stationary phase (upper). Then rotation of the coils (1600 rpm) was initiated and the mobile phase (lower phase) was pumped until exiting at the outlet of the coils. Initially, separation was performed on an analytical scale. A portion of the crude extract (33 mg) was dissolved in a mixture of the upper (0.5 mL) and lower (0.5 mL) phases. The mixture was injected through a 1 mL sample loop, and the mobile phase was pumped at a flow rate of 1 mL min -1 . In order to scale-up the optimal separation conditions, a sample of the extract (200 mg) was dissolved in the biphasic solvent system (6 mL) and injected into a preparative coil using a 6 mL sample loop. The flow rate of the mobile phase was then increased to 6 mL min -1 . Each separation was performed at 30ºC. Fractions were collected every one minute, then evaporated under reduced pressure and dissolved in methanol for subsequent purity analysis by HPLC.
Animals and experimental conditions
Adult male Swiss albino mice (weighing 20-26 g, sixweek-old) were purchased from a licensed breeder (Dr. J. Kolacz, Warszawa, Poland). The animals were kept in colony cages (20 mice per cage) with free access to food and tap water, under standardized housing conditions (12 h light-dark cycle, temperature of 23±1ºC, relative humidity of 55±5%). After 7 days of acclimatization to the laboratory conditions, the animals were randomly assigned to experimental groups comprised of 8 mice. Each mouse was used only once, and all tests were performed between 08.00 and 15.00 hours. Procedures involving animals and their care were conducted in accordance with current European Community and Polish legislation on animal experimentation. Additionally, all efforts were made to minimize animal suffering, and to use only the number of animals necessary to produce reliable scientific data. The experimental protocols and procedures described in this manuscript were approved by the Second Local Ethics Committee at the University of Life Sciences, Lublin, Poland (License No.: 4/2012) and complied with the European Communities Council Directive of 24 November 1986 (86/609/EEC). The total number of animals used in this study was 128. 
Drug administration
Maximal electroshock seizure test
Electroconvulsions were produced by means of an alternating current stimulation (sine-wave, 25 mA, 50 Hz, 500 V, 0.2 s stimulus duration) and delivered via ear-clip electrodes by a Rodent Shocker generator (Type 221, Hugo Sachs Elektronik, Freiburg, Germany). The criterion for the occurrence of seizure activity was the tonic hind limb extension. The anticonvulsant activity of xanthotoxin (administered at pretreatment times of 15, 30, 60, and 120 min) was determined as its median effective doses (ED 50 values in mg kg -1 ) in the MES-induced seizure test in mice. In order to obtain a variable percentage of protection against electroconvulsions different doses of xanthotoxin were administered and dose-response relationship lines for the examined compound administered i.p. at various pretreatment times, according to Litchfield and Wilcoxon was constructed [9] . To determine the ED 50 values (the dose of xanthotoxin required to protect half of the animals tested against MES-induced seizures), the compound was administered at doses ranging between 150 and 350 mg kg -1 . This experimental procedure has been described in more detail in our previous papers [4, 5, 10, 11] .
Results and Discussion
HPCCC fractionation
HPLC analysis of the dichloromethane extract of the fruits of Pastinaca sativa showed that xanthotoxin is one of the major compounds (Figure 1) . Therefore extracts were subjected to separation for this active molecule. Prior to HPCCC analysis, the solvent systems were optimized. The composition of the two-phase solvent system was selected according to the distribution coefficient of xanthotoxin (K), which is the ratio of the peak area in the stationary phase to the peak area in the mobile phase. Different mixtures of n-heptane-ethyl acetate-methanol-water were evaluated, and the area of target compound was calculated by HPLC analysis and K values were obtained. A mixture of n-heptane-ethyl acetate-methanol-water (1:1:1:1 v/v/v/v) was selected as a suitable system for the separation. In this system, the K value for xanthotoxin was 0.92. Optimal conditions for separation were established using an analytical coil system, and these conditions were scaled to semipreparative conditions. Separations were performed in a reversed phase mode, where the upper phase was the stationary phase. A total of forty-five fractions were collected, and xanthotoxin was detected in fractions 19-21 (separation in analytical conditions presented in Figure 2 ). The HPLC chromatogram of the isolated xanthotoxin, together with its UV/DAD spectrum, is presented in Figure 3 , and confirmed the purity of the isolated compound (98%). The yield of purified xanthotoxin from the injection of crude extract (200 mg) was 7.2 mg. Previously, xanthotoxin was purified from the fruits of Cnidium monnieri (L.) Spreng. (Apiaceae) using high speed counter-current chromatography (HSCCC), but a very long time was needed to complete the separation in both instances. Liu et al. [12] proposed stepwise elution with a pair of two-phase solvent systems composed of light petroleum-ethyl acetate-methanol-water at volume ratios of 5:5:5:5, 5:5:6:4, and 5:5:6.5:3.5. Xanthotoxin was collected immediately after changing the mobile (lower) phase of the solvent system from 5:5:5:5 to 5:5:6:4 (150 min). The mobile phase was pumped at 2 mL min -1 . Li and Chen finished the purification of xanthotoxin after 9 h using stepwise elution systems composed of n-hexaneethyl acetate-ethanol-water when ratios of 5:5:4:6 and 5:5:6:4 were applied [13] . In the present experiment, high-performance counter-current chromatography was applied as a new generation technique producing higher g fields, thus allowing higher flow rates and reducing the separation times to minutes from hours, while maintaining resolution and elution times [14] . Thus, xanthotoxin was purified after 25 min instead of the respectively [5] . The time-course and dose-response effect revealed that xanthotoxin is most effective when administered at 60 min before electroconvulsion induction (ED 50 = 219.1± 4.7 mg kg -1 ; Table 1 ). These results suggest that xanthotoxin possesses anticonvulsant effects comparable to the conventional drug, which has a number of side effects. The activity of xanthotoxin is weaker than that of imperatorin, which may be related to the conformation; elongation of the aliphatic chain at C-8 resulted in increased antiepileptic activity. Further several hours needed previously. The selection of an appropriate solvent system, which affords a distribution ratio of about 1, effectively guarantees elution after about one column volume of the mobile phase has been processed through the column. 
Anticonvulsant action of xanthotoxin against maximal electroshock-induced seizures in mice
Conclusions
This study indicated for the first time that xanthotoxin produced a clear anti-electroshock effect in the mouse maximal electroshock-induced seizure model. A high-performance counter-current chromatography (HPCCC) method was developed for the rapid preparative isolation of the test compound from the fruits of Pastinaca sativa.
